Big telehealth brands scaled back compounded GLP-1. Here's what your options are now.
If you were getting compounded GLP-1 care through a large telehealth platform and your program changed, you're not alone — and you're not out of options. Over the past year, several of the biggest names in telehealth narrowed or stepped back from compounded GLP-1 offerings as business and supply conditions shifted. This page explains, plainly, what changed and how to evaluate where to go next.
What actually changed
- Several large platforms shifted their focus, often toward branded medications or away from compounded offerings, as market and supply conditions changed. These were company business decisions.
- Compounded medications remain available through licensed compounding pharmacies with a valid prescription, where clinically appropriate.
- No claim about the regulatory status of compounding itself — that is a separate, evolving topic this page does not address.
What to look for in a new provider
- One all-in price shown up front — not a teaser that climbs as your dose increases, and no separate membership fee stacked on top.
- A licensed provider reviews every request and decides what's appropriate — not an automatic yes.
- LegitScript certification (you can verify it independently).
- Clear cancellation — in writing, no retention-call maze.
- Honest disclosures — including that compounded medications are not FDA-approved.
Where Vyvron fits
Vyvron is a LegitScript-certified telehealth program that still offers compounded GLP-1 where a licensed provider decides it's appropriate, at one all-in price — $179 every 4 weeks for a limited time (regularly $199), no hidden fees, cancel anytime. Available in 49 states (not Mississippi for compounded medications).